<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To investigate the effect of an <z:chebi fb="11" ids="22586">antioxidant</z:chebi> <z:chebi fb="0" ids="31530">edaravone</z:chebi> on the apoptotic process, we examined Bax and Bcl-2 immunohistochemical expression and terminal deoxynucleotidyl transferase-mediated <z:chebi fb="0" ids="17625">dUTP</z:chebi>-<z:chebi fb="1" ids="15956">biotin</z:chebi> nick end labeling (TUNEL) reactivity </plain></SENT>
<SENT sid="1" pm="."><plain>Rat focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> models were prepared by 2 h transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="31530">Edaravone</z:chebi> or physiological saline was intravenously administered after reperfusion </plain></SENT>
<SENT sid="3" pm="."><plain>After 24 h of reperfusion, infarction volume assessments, Bax and Bcl-2 immunohistochemistry and TUNEL staining were performed as well as neurological evaluation </plain></SENT>
<SENT sid="4" pm="."><plain>Cortical cerebral blood flow was not statistically different between the treatment-groups </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="0" ids="31530">Edaravone</z:chebi>-treated animals showed significantly improved neurological outcome </plain></SENT>
<SENT sid="6" pm="."><plain>Total and cortical <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes in the <z:chebi fb="0" ids="31530">edaravone</z:chebi> group significantly decreased </plain></SENT>
<SENT sid="7" pm="."><plain>In addition, <z:chebi fb="0" ids="31530">edaravone</z:chebi>-treatment provided a significant reduction in the number of TUNEL-positive apoptotic cells, a decrease in Bax immunoreactivity and an increase in Bcl-2 expression within the peri-<z:mpath ids='MPATH_124'>infarct</z:mpath> area </plain></SENT>
<SENT sid="8" pm="."><plain><z:chebi fb="0" ids="31530">Edaravone</z:chebi> shows an excellent neuroprotective effect against <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion brain injury through a Bax/Bcl-2 dependent anti-apoptotic mechanism </plain></SENT>
</text></document>